GlobalData on MSN2d
23andMe weighing up sale of the company as cash runs dryMe is considering a sale of the company as it weighs up strategic options, capping a torrid year for the genetic testing ...
SUNNYVALE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help ...
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...
By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...
23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an earnings call in February last year. She said the biotech company, which offers direct-to-consumer genetic testing ...
23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...
The DNA-testing company is exploring its options, including a business combination and the sale of some or all of its assets.
The Special Committee of the board of 23andMe Holding Co. announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a poss ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback